MX2023013616A - Composiciones para el tratamiento de condiciones neurodegenerativas. - Google Patents
Composiciones para el tratamiento de condiciones neurodegenerativas.Info
- Publication number
- MX2023013616A MX2023013616A MX2023013616A MX2023013616A MX2023013616A MX 2023013616 A MX2023013616 A MX 2023013616A MX 2023013616 A MX2023013616 A MX 2023013616A MX 2023013616 A MX2023013616 A MX 2023013616A MX 2023013616 A MX2023013616 A MX 2023013616A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- compositions
- neurodegenerative conditions
- disclosed
- solid state
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189880P | 2021-05-18 | 2021-05-18 | |
| PCT/US2022/027294 WO2022245532A1 (en) | 2021-05-18 | 2022-05-02 | Compositions for treatment of neurodegenerative conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023013616A true MX2023013616A (es) | 2024-01-17 |
Family
ID=84141848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023013616A MX2023013616A (es) | 2021-05-18 | 2022-05-02 | Composiciones para el tratamiento de condiciones neurodegenerativas. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240108636A1 (https=) |
| EP (1) | EP4341271A4 (https=) |
| JP (1) | JP2024519079A (https=) |
| AU (1) | AU2022275684A1 (https=) |
| CA (1) | CA3218191A1 (https=) |
| MX (1) | MX2023013616A (https=) |
| WO (1) | WO2022245532A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024054452A1 (en) * | 2022-09-06 | 2024-03-14 | Biovie Inc. | Methods for the treatment of mild cognitive impairment |
| WO2025155561A1 (en) * | 2024-01-16 | 2025-07-24 | Biovie Inc. | Methods of treating long covid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070015763A1 (en) * | 2005-07-12 | 2007-01-18 | Pfizer Inc | Treatment of psychosis associated with parkinson's disease and subcortical dementias using a combination of an atypical antipsychotic with a dopamine agonist |
| DK2273994T3 (en) * | 2008-04-03 | 2016-02-01 | Neurmedix Inc | PHARMACEUTICAL FORMS OF A MEDICINE |
-
2022
- 2022-05-02 EP EP22805164.5A patent/EP4341271A4/en active Pending
- 2022-05-02 MX MX2023013616A patent/MX2023013616A/es unknown
- 2022-05-02 JP JP2023571820A patent/JP2024519079A/ja active Pending
- 2022-05-02 AU AU2022275684A patent/AU2022275684A1/en active Pending
- 2022-05-02 CA CA3218191A patent/CA3218191A1/en active Pending
- 2022-05-02 WO PCT/US2022/027294 patent/WO2022245532A1/en not_active Ceased
-
2023
- 2023-11-16 US US18/511,027 patent/US20240108636A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022245532A1 (en) | 2022-11-24 |
| US20240108636A1 (en) | 2024-04-04 |
| EP4341271A1 (en) | 2024-03-27 |
| AU2022275684A1 (en) | 2023-11-16 |
| JP2024519079A (ja) | 2024-05-08 |
| EP4341271A4 (en) | 2025-04-30 |
| CA3218191A1 (en) | 2022-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA522433155B1 (ar) | مركبات ثلاثية الحلقة مستبدلة | |
| UA130338C2 (uk) | Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування | |
| BR112022018646A2 (pt) | Composto agonista do receptor glp-1, composição farmacêutica compreendendo o mesmo, métodos para preparar o composto e uso do dito composto para prevenir ou tratar uma doença metabólica ou uma doença neurodegenerativa | |
| DOP2009000148A (es) | Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides | |
| BRPI0515412A (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
| BRPI1009381B8 (pt) | compostos, composição farmacêutica e uso de compostos e de composição farmacêutica | |
| MX2021010122A (es) | Compuestos de imidazopiridinilo y su uso para el tratamiento de trastornos neurodegenerativos. | |
| EA201101671A1 (ru) | Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина | |
| EA200901159A1 (ru) | Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она | |
| EA200901160A1 (ru) | Производные 3-циано-4-(4-тетрагидропиранфенил)пиридин-2-она | |
| EA200702339A1 (ru) | Замещенные амидные производные в качестве ингибиторов протеинкиназы | |
| EA200900178A1 (ru) | Конденсированные гетероциклические производные и их применение | |
| EA201390947A1 (ru) | Соединения 2-амино-4-арилтиазола в качестве антагонистов trpa1 | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| MY209839A (en) | Oxadiazole transient receptor potential channel inhibitors | |
| BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
| AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
| MX2023013616A (es) | Composiciones para el tratamiento de condiciones neurodegenerativas. | |
| BR112021011325A2 (pt) | Derivados de rapamicina | |
| BR112018069712A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a. | |
| EA200800081A1 (ru) | Бензамидные производные (варианты), содержащая их фармацевтическая композиция (варианты), способ лечения заболеваний, связанных с модуляцией гидроксистероиддегидрогеназ на основе указанных производных(варианты) | |
| BR112012025590A2 (pt) | análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 | |
| CY1124346T1 (el) | ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ | |
| EA201190234A1 (ru) | Новые амидные производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью | |
| ZA202107777B (en) | Voruciclib polymorphs and methods of making and using thereof |